Aethlon Medical Corp - AEMD Real Price to Acquire Entire Company

The Enterprise Value characteristic for Aethlon Medical (AEMD) is 3.57, while Aethlon Medical (AEMD) utilizes external capacities to produce complex filters while maintaining full control over its patents. The business model relies on the Hemopurifier, creating a unique method for clearing pathogens from the blood. The implementation of these systems in intensive care units guarantees stable demand for consumables, providing the company with a sustainable cash flow.

Enterprise value represents the total acquisition price of a business, combining market capitalization and net debt. Analyzing the calculated enterprise value allows for an assessment of the real financial burden on Aethlon Medical (AEMD), taking into account the costs of developing unique pathogen filtration systems. This metric determines the extent to which the market valuation of the innovative blood purification method aligns with the company's actual liabilities and liquidity.